STAT June 28, 2024
A new and effective class of anti-obesity medicines, along with lifestyle interventions and sometimes bariatric surgery, can help stem the rising tide of obesity in the United States. But outdated rules set by the Centers for Medicare and Medicaid Services make access to these new medicines nearly impossible for the 50 million Americans covered by Medicare and its prescription drug coverage program.
The American Heart Association (AHA) first recognized obesity as a risk factor for cardiovascular disease in 1998. Yet more than 25 years later, skyrocketing rates of obesity remain one of the leading causes of compromised cardiovascular health, and cardiovascular disease is still the leading cause of death in the United States.
Black Americans have suffered disproportionately: no other...
Today's Sponsors
Today's Sponsor